Because women with a germline mutation in BRCA1 have such a drastically increased incidence in breast cancer risk, this mutation afforded the opportunity to examine how the DEABM would perform in reproducing cumulative risk of breast cancer over time. The gene discussed is BRCA1; the disease is breast carcinoma.